2013 Access Advocacy Patients 
NORML
MAY 12, 2020
She was diagnosed with Multiple Sclerosis in 2013, and for a few years believed she could continue to teach and live her life as long as she followed all the doctors recommendations and took the medications they prescribed. It concerned her that even as a registered patient, she could still be arrested.
NORML
MARCH 3, 2020
The MRTA ( Marijuana Regulation and Taxation Act ) was first introduced by Assembly Majority Leader Crystal Peoples-Stokes and Senator Liz Krueger in 2013, and has been re-introduced every session since. Medical patients are restricted to 4 plants total, per household. Access to commonly found cannabis products in the regulated market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
APRIL 2, 2021
The name of the event is a reference to the Realm of Caring (RoC), a nonprofit dedicated to supporting research into cannabinoids and helping patients who need them gain access to lifesaving medications. She was the sort of patient zero, if you will,” Jackson said in a virtual interview. “So She was the catalyst.
NORML
DECEMBER 10, 2019
During her terms, she introduced two marijuana legalization bills, first in 2011 and again in 2013. That can really hurt patients, especially if people grow normally for medical, and suddenly they want to grow high-THC for adult-use. They may stop growing the type of products that medical patients need.
Cannabis Law Report
JULY 25, 2022
We see a lot of people out there who are suffering, and we’re determined to bring these therapies into the medical system so psychiatrists can use them with their patients,” Peter says. He is an outspoken commentator on Climate Change and Security using community advocacy to raise awareness of the potential costs of inaction.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The review, however, did not cover patient access to medicinal cannabis. A recent study by Lintzeris et al.
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. Relevant AAFP Policy. Call to Action.
Expert insights. Personalized for you.
274 
Let's personalize your content